After submitting the device for clearance last July, TTS has been patiently awaiting FDA approval, which would allow for a quick release and exploration of other applications like chemotherapy. Now, with the credentials in place, the company has already received its first purchase order from a large medical center (details confidential) and is looking to expand their product roll-out next month.
The reason for working with this medical center is to get feedback from the patients, from the technicians who use the device and get some clinical data from the physicians about how things are going, says TTS CEO Raymond Vennare. Its really going to be about us understanding if we have to tweak anything, getting through the last little stuff to ensure its operating the way people want it to operate.
By increasing the flow of fluids into chest and tissue cavities, the Veratherm Portable Hyperthermic Perfusion System increases the speed with which fluids can be transmitted through the abdominal cavity, a process that may have applications for the delivery of chemotherapy drugs. While similar devices exist today, many technology blogs and media outlets have reported Veratherm for its portability. Weighing just 26 pounds and standing just one foot high, Vennare hopes the system will have applications for the military and other emergency situations.
We know the Department of Defense has funded at least one other device like this, light enough to put on the planes when they transport patients. Ours is not a battlefield design but it is definitely designed for mobility and is small enough and simple enough that it can be moved from room to room and from place to place, says Vennare. Right now, we want to put this in the hands of as many technicians as possible.
Source: Raymond Vennare, Thermal Therapeutic Systems
Writer: John Steele
